A 8-WEEK, RANDOMIZED, DOUBLE-MASKED, PARALLEL GROUP, PHASE III STUDY COMPARING THE EFFICACY AND SAFETY OF XALACOM AND XALATAN IN PATIENTS WITH PRIMARY OPEN ANGLE GLAUCOMA (POAG) OR OCULAR HYPERTENSION (OH)
A 8-WEEK, RANDOMIZED, DOUBLE-MASKED, PARALLEL GROUP, PHASE III STUDY COMPARING THE EFFICACY AND SAFETY OF XALACOM AND XALATAN IN PATIENTS WITH PRIMARY OPEN ANGLE GLAUCOMA (POAG) OR OCULAR HYPERTENSION (OH)
This study will examine the efficacy and safety of Xalacom comparing with those of Xalatan in Japanese patients with POAG or OH, in order to show superiority of Xalacom over Xalatan in efficacy and similarity of safety between Xalacom and Xalatan.
Inclusion Criteria:
Exclusion Criteria:
Koube, Hyōgo 650-0017, Japan
Bunkyo-ku, Tokyo 113-8655, Japan
Chiyoda-ku, Tokyo 101-0062, Japan
Koto-ku, Tokyo 136-0076, Japan
Meguro-ku, Tokyo 153-0043, Japan
Taito-ku, Tokyo 110-015, Japan
Fujuoka, 812-0011, Japan